Last 12 months
Inside the activity.
0 purchase rows · 46 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 15 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 02, 2019 Filed Dec 3, 2019 21:20 UTC |
Flannelly Barry PEVP & General Manager US
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,582 | $0.00 Strike: $73.21 | $0.00 |
DisclosureSEC source: 0001209191-19-058699 · doc4.xml · derivative · entry 6 Flannelly Barry P · CIK 0001615842 · EVP & General Manager US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,764 Underlying: Common Stock · 6,582 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Beginning January 8, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 21:20 UTC |
Flannelly Barry PEVP & General Manager US
|
SaleCommon Stock | 6,582 | $95.00 | $625,290.00 |
DisclosureSEC source: 0001209191-19-058699 · doc4.xml · nonDerivative · entry 4 Flannelly Barry P · CIK 0001615842 · EVP & General Manager US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,979 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F2 · balance_after: Includes an aggregate of 13,951 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 21:20 UTC |
Flannelly Barry PEVP & General Manager US
|
Exercise / conversionCommon Stock | 6,582 | $73.21 | $481,868.22 |
DisclosureSEC source: 0001209191-19-058699 · doc4.xml · nonDerivative · entry 3 Flannelly Barry P · CIK 0001615842 · EVP & General Manager US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,561 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 21:32 UTC |
Wenqing YaoEVP, Head of Discovery Chem
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,165 | $0.00 Strike: $18.32 | $0.00 |
DisclosureSEC source: 0001209191-19-058714 · doc4.xml · derivative · entry 5 Wenqing Yao · CIK 0001624033 · EVP, Head of Discovery Chem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,377 Underlying: Common Stock · 3,165 shares Expires 2020-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 21:32 UTC |
Wenqing YaoEVP, Head of Discovery Chem
|
SaleCommon Stock | 3,165 | $95.00 | $300,675.00 |
DisclosureSEC source: 0001209191-19-058714 · doc4.xml · nonDerivative · entry 2 Wenqing Yao · CIK 0001624033 · EVP, Head of Discovery Chem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,308 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 21:32 UTC |
Wenqing YaoEVP, Head of Discovery Chem
|
Exercise / conversionCommon Stock | 3,165 | $18.32 | $57,982.80 |
DisclosureSEC source: 0001209191-19-058714 · doc4.xml · nonDerivative · entry 1 Wenqing Yao · CIK 0001624033 · EVP, Head of Discovery Chem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 21:25 UTC |
Iyengar Vijay KEVP GPS, BD, & Licensing
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 500 | $0.00 Strike: $72.86 | $0.00 |
DisclosureSEC source: 0001209191-19-058709 · doc4.xml · derivative · entry 5 Iyengar Vijay K · CIK 0001670000 · EVP GPS, BD, & Licensing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,098 Underlying: Common Stock · 500 shares Expires 2023-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Beginning May 9, 2016, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 21:25 UTC |
Iyengar Vijay KEVP GPS, BD, & Licensing
|
SaleCommon Stock | 500 | $95.00 | $47,500.00 |
DisclosureSEC source: 0001209191-19-058709 · doc4.xml · nonDerivative · entry 2 Iyengar Vijay K · CIK 0001670000 · EVP GPS, BD, & Licensing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,609 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 21:25 UTC |
Iyengar Vijay KEVP GPS, BD, & Licensing
|
Exercise / conversionCommon Stock | 500 | $72.86 | $36,430.00 |
DisclosureSEC source: 0001209191-19-058709 · doc4.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP GPS, BD, & Licensing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 21:20 UTC |
Flannelly Barry PEVP & General Manager US
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 600 | $0.00 Strike: $73.21 | $0.00 |
DisclosureSEC source: 0001209191-19-058699 · doc4.xml · derivative · entry 5 Flannelly Barry P · CIK 0001615842 · EVP & General Manager US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,346 Underlying: Common Stock · 600 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Beginning January 8, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 21:20 UTC |
Flannelly Barry PEVP & General Manager US
|
SaleCommon Stock | 600 | $95.00 | $57,000.00 |
DisclosureSEC source: 0001209191-19-058699 · doc4.xml · nonDerivative · entry 2 Flannelly Barry P · CIK 0001615842 · EVP & General Manager US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,979 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 21:20 UTC |
Flannelly Barry PEVP & General Manager US
|
Exercise / conversionCommon Stock | 600 | $73.21 | $43,926.00 |
DisclosureSEC source: 0001209191-19-058699 · doc4.xml · nonDerivative · entry 1 Flannelly Barry P · CIK 0001615842 · EVP & General Manager US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:31 UTC |
Flannelly Barry PEVP & General Manager US
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 1,720 | $0.00 Strike: $48.44 | $0.00 |
DisclosureSEC source: 0001209191-19-058122 · doc4.xml · derivative · entry 6 Flannelly Barry P · CIK 0001615842 · EVP & General Manager US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,720 shares Expires 2021-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Beginning August 11, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:31 UTC |
Flannelly Barry PEVP & General Manager US
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 422 | $0.00 Strike: $48.44 | $0.00 |
DisclosureSEC source: 0001209191-19-058122 · doc4.xml · derivative · entry 5 Flannelly Barry P · CIK 0001615842 · EVP & General Manager US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 422 shares Expires 2021-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Beginning August 11, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:31 UTC |
Flannelly Barry PEVP & General Manager US
|
SaleCommon Stock | 1,720 | $90.00 | $154,800.00 |
DisclosureSEC source: 0001209191-19-058122 · doc4.xml · nonDerivative · entry 4 Flannelly Barry P · CIK 0001615842 · EVP & General Manager US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,979 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F2 · balance_after: Includes an aggregate of 13,951 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:31 UTC |
Flannelly Barry PEVP & General Manager US
|
Exercise / conversionCommon Stock | 1,720 | $48.44 | $83,316.80 |
DisclosureSEC source: 0001209191-19-058122 · doc4.xml · nonDerivative · entry 3 Flannelly Barry P · CIK 0001615842 · EVP & General Manager US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,699 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:31 UTC |
Flannelly Barry PEVP & General Manager US
|
SaleCommon Stock | 422 | $90.00 | $37,980.00 |
DisclosureSEC source: 0001209191-19-058122 · doc4.xml · nonDerivative · entry 2 Flannelly Barry P · CIK 0001615842 · EVP & General Manager US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,979 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:31 UTC |
Flannelly Barry PEVP & General Manager US
|
Exercise / conversionCommon Stock | 422 | $48.44 | $20,441.68 |
DisclosureSEC source: 0001209191-19-058122 · doc4.xml · nonDerivative · entry 1 Flannelly Barry P · CIK 0001615842 · EVP & General Manager US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:11 UTC |
Wenqing YaoEVP, Head of Discovery Chem
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $18.32 | $0.00 |
DisclosureSEC source: 0001209191-19-058098 · doc4.xml · derivative · entry 3 Wenqing Yao · CIK 0001624033 · EVP, Head of Discovery Chem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,542 Underlying: Common Stock · 15,000 shares Expires 2020-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:11 UTC |
Wenqing YaoEVP, Head of Discovery Chem
|
SaleCommon Stock | 15,000 | $90.00 | $1,350,000.00 |
DisclosureSEC source: 0001209191-19-058098 · doc4.xml · nonDerivative · entry 2 Wenqing Yao · CIK 0001624033 · EVP, Head of Discovery Chem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,308 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F2 · balance_after: This includes an aggregate of 63,951 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:11 UTC |
Wenqing YaoEVP, Head of Discovery Chem
|
Exercise / conversionCommon Stock | 15,000 | $18.32 | $274,800.00 |
DisclosureSEC source: 0001209191-19-058098 · doc4.xml · nonDerivative · entry 1 Wenqing Yao · CIK 0001624033 · EVP, Head of Discovery Chem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:06 UTC |
Trower PaulPrincipal Accounting Officer
|
Exercise / conversionNon Qualfied Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $18.32 | $0.00 |
DisclosureSEC source: 0001209191-19-058092 · doc4.xml · derivative · entry 3 Trower Paul · CIK 0001642041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2020-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:06 UTC |
Trower PaulPrincipal Accounting Officer
|
SaleCommon Stock | 15,000 | $90.00 | $1,350,000.00 |
DisclosureSEC source: 0001209191-19-058092 · doc4.xml · nonDerivative · entry 2 Trower Paul · CIK 0001642041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,306 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F2 · price: Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. F3 · price: Represents weighted average sale price. Actual sale prices ranged from $90.00 - $90.02. F4 · balance_after: This includes an 6,993 aggregate of shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:06 UTC |
Trower PaulPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 15,000 | $18.32 | $274,800.00 |
DisclosureSEC source: 0001209191-19-058092 · doc4.xml · nonDerivative · entry 1 Trower Paul · CIK 0001642041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,306 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 22:45 UTC |
SWAIN PAULA JEVP, Human Resources
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $64.55 | $0.00 |
DisclosureSEC source: 0001209191-19-057276 · doc4.xml · derivative · entry 3 SWAIN PAULA J · CIK 0001236934 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,139 Underlying: Common Stock · 2,500 shares Expires 2021-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Beginning January 21, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 22:45 UTC |
SWAIN PAULA JEVP, Human Resources
|
SaleCommon Stock | 2,500 | $86.46 | $216,150.00 |
DisclosureSEC source: 0001209191-19-057276 · doc4.xml · nonDerivative · entry 2 SWAIN PAULA J · CIK 0001236934 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,612 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F2 · balance_after: This includes an aggregate of 13,951 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 22:45 UTC |
SWAIN PAULA JEVP, Human Resources
|
Exercise / conversionCommon Stock | 2,500 | $64.55 | $161,375.00 |
DisclosureSEC source: 0001209191-19-057276 · doc4.xml · nonDerivative · entry 1 SWAIN PAULA J · CIK 0001236934 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2019 Filed Nov 14, 2019 22:32 UTC |
Pasquale Maria EEVP & General Counsel
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 76 | $0.00 Strike: $65.36 | $0.00 |
DisclosureSEC source: 0001209191-19-056610 · doc4.xml · derivative · entry 2 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,664 Underlying: Common Stock · 76 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Beginning April 9, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| November 13, 2019 Filed Nov 14, 2019 22:32 UTC |
Pasquale Maria EEVP & General Counsel
|
Exercise / conversionCommon Stock | 76 | $65.36 | $4,967.36 |
DisclosureSEC source: 0001209191-19-056610 · doc4.xml · nonDerivative · entry 1 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This includes an aggregate of 15,249 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| November 08, 2019 Filed Nov 8, 2019 22:25 UTC |
DIXON WENDY LDirector
|
Exercise / conversionNon Qualfied Stock Option (right to buy) · Derivative | 18,334 | $0.00 Strike: $12.46 | $0.00 |
DisclosureSEC source: 0001209191-19-055857 · doc4.xml · derivative · entry 12 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,334 shares Expires 2020-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Beginning May 21, 2010, options become exercisable in full on May 21, 2011. Read SEC document |
| November 08, 2019 Filed Nov 8, 2019 22:25 UTC |
DIXON WENDY LDirector
|
Exercise / conversionNon Qualfied Stock Option (right to buy) · Derivative | 22,884 | $0.00 Strike: $12.46 | $0.00 |
DisclosureSEC source: 0001209191-19-055857 · doc4.xml · derivative · entry 11 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,884 shares Expires 2020-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Beginning May 21, 2010, options become exercisable in 37 installments, with the first 25.00% vesting on May 21, 2011 and the remainder vesting monthly over three years. Read SEC document |
| November 08, 2019 Filed Nov 8, 2019 22:25 UTC |
DIXON WENDY LDirector
|
SaleCommon Stock | 18,334 | $83.87 | $1,537,672.58 |
DisclosureSEC source: 0001209191-19-055857 · doc4.xml · nonDerivative · entry 8 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,340 F1 · price: Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. F4 · price: Represents weighted average sale price. Actual sale prices ranged from $83.12 - $84.21. F5 · balance_after: This includes an 1,520 aggregate of shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| November 08, 2019 Filed Nov 8, 2019 22:25 UTC |
DIXON WENDY LDirector
|
Exercise / conversionCommon Stock | 18,334 | $12.46 | $228,441.64 |
DisclosureSEC source: 0001209191-19-055857 · doc4.xml · nonDerivative · entry 7 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,674 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2019 Filed Nov 8, 2019 22:25 UTC |
DIXON WENDY LDirector
|
SaleCommon Stock | 22,884 | $83.87 | $1,919,281.08 |
DisclosureSEC source: 0001209191-19-055857 · doc4.xml · nonDerivative · entry 6 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,340 F1 · price: Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. F4 · price: Represents weighted average sale price. Actual sale prices ranged from $83.12 - $84.21. Read SEC document |
| November 08, 2019 Filed Nov 8, 2019 22:25 UTC |
DIXON WENDY LDirector
|
Exercise / conversionCommon Stock | 22,884 | $12.46 | $285,134.64 |
DisclosureSEC source: 0001209191-19-055857 · doc4.xml · nonDerivative · entry 5 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2019 Filed Nov 8, 2019 22:25 UTC |
DIXON WENDY LDirector
|
Exercise / conversionNon Qualfied Stock Option (right to buy) · Derivative | 1,540 | $0.00 Strike: $12.46 | $0.00 |
DisclosureSEC source: 0001209191-19-055857 · doc4.xml · derivative · entry 10 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,884 Underlying: Common Stock · 1,540 shares Expires 2020-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Beginning May 21, 2010, options become exercisable in 37 installments, with the first 25.00% vesting on May 21, 2011 and the remainder vesting monthly over three years. Read SEC document |
| November 07, 2019 Filed Nov 8, 2019 22:25 UTC |
DIXON WENDY LDirector
|
SaleCommon Stock | 1,540 | $83.60 | $128,744.00 |
DisclosureSEC source: 0001209191-19-055857 · doc4.xml · nonDerivative · entry 4 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,340 F1 · price: Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. F3 · price: Represents weighted average sale price. Actual sale prices ranged from $83.50 - $83.70. Read SEC document |
| November 07, 2019 Filed Nov 8, 2019 22:25 UTC |
DIXON WENDY LDirector
|
Exercise / conversionCommon Stock | 1,540 | $12.46 | $19,188.40 |
DisclosureSEC source: 0001209191-19-055857 · doc4.xml · nonDerivative · entry 3 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 22:25 UTC |
DIXON WENDY LDirector
|
Exercise / conversionNon Qualfied Stock Option (right to buy) · Derivative | 10,576 | $0.00 Strike: $12.46 | $0.00 |
DisclosureSEC source: 0001209191-19-055857 · doc4.xml · derivative · entry 9 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,424 Underlying: Common Stock · 10,576 shares Expires 2020-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Beginning May 21, 2010, options become exercisable in 37 installments, with the first 25.00% vesting on May 21, 2011 and the remainder vesting monthly over three years. Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 22:25 UTC |
DIXON WENDY LDirector
|
SaleCommon Stock | 10,576 | $84.16 | $890,076.16 |
DisclosureSEC source: 0001209191-19-055857 · doc4.xml · nonDerivative · entry 2 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,340 F1 · price: Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. F2 · price: Represents weighted average sale price. Actual sale prices ranged from $84.10 - $84.30. Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 22:25 UTC |
DIXON WENDY LDirector
|
Exercise / conversionCommon Stock | 10,576 | $12.46 | $131,776.96 |
DisclosureSEC source: 0001209191-19-055857 · doc4.xml · nonDerivative · entry 1 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,916 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 22:23 UTC |
Wenqing YaoEVP, Head of Discovery Chem
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,960 | $0.00 Strike: $18.32 | $0.00 |
DisclosureSEC source: 0001209191-19-055288 · doc4.xml · derivative · entry 3 Wenqing Yao · CIK 0001624033 · EVP, Head of Discovery Chem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,542 Underlying: Common Stock · 7,960 shares Expires 2020-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 22:23 UTC |
Wenqing YaoEVP, Head of Discovery Chem
|
SaleCommon Stock | 7,960 | $85.00 | $676,600.00 |
DisclosureSEC source: 0001209191-19-055288 · doc4.xml · nonDerivative · entry 2 Wenqing Yao · CIK 0001624033 · EVP, Head of Discovery Chem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,308 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F2 · balance_after: This includes an aggregate of 63,951 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 22:23 UTC |
Wenqing YaoEVP, Head of Discovery Chem
|
Exercise / conversionCommon Stock | 7,960 | $18.32 | $145,827.20 |
DisclosureSEC source: 0001209191-19-055288 · doc4.xml · nonDerivative · entry 1 Wenqing Yao · CIK 0001624033 · EVP, Head of Discovery Chem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,268 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 21:33 UTC |
Trower PaulPrincipal Accounting Officer
|
Exercise / conversionNon Qualfied Stock Option (right to buy) · Derivative | 8,500 | $0.00 Strike: $18.32 | $0.00 |
DisclosureSEC source: 0001209191-19-055212 · doc4.xml · derivative · entry 3 Trower Paul · CIK 0001642041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 8,500 shares Expires 2020-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 21:33 UTC |
Trower PaulPrincipal Accounting Officer
|
SaleCommon Stock | 8,500 | $85.00 | $722,500.00 |
DisclosureSEC source: 0001209191-19-055212 · doc4.xml · nonDerivative · entry 2 Trower Paul · CIK 0001642041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,306 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F2 · balance_after: This includes an 6,993 aggregate of shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 21:33 UTC |
Trower PaulPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 8,500 | $18.32 | $155,720.00 |
DisclosureSEC source: 0001209191-19-055212 · doc4.xml · nonDerivative · entry 1 Trower Paul · CIK 0001642041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2019 Filed Oct 31, 2019 20:10 UTC |
Wenqing YaoEVP, Head of Discovery Chem
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-054622 · doc4.xml · nonDerivative · entry 3 Wenqing Yao · CIK 0001624033 · EVP, Head of Discovery Chem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,308 F2 · shares: Represents shares of common stock underlying performance shares earned upon the achievement of performance criteria determined to be satisfied on October 30, 2019. The performance shares vest 100% on the third anniversary of the grant date of June 28, 2018, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. Each performance share initially represented the right to receive one or more shares of common stock based on, and subject to, the achievement of certain clinical milestones determined by the Issuer's Compensation Committee in October 2019 as set forth in the Performance Share Award Agreement. The number of shares of common stock that the Reporting Person was entitled to receive ranged from 0% to 100% of the number of performance shares awarded, and the performance criteria was achieved at the 100% level. F3 · balance_after: This includes an aggregate of 63,951 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| October 30, 2019 Filed Oct 31, 2019 20:04 UTC |
Stein Steven HEVP & Chief Medical Officer
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-054618 · doc4.xml · nonDerivative · entry 1 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,473 F1 · shares: Represents shares of common stock underlying performance shares earned upon the achievement of performance criteria determined to be satisfied on October 30, 2019. The performance shares vest 100% on the third anniversary of the grant date of June 28, 2018, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. Each performance share initially represented the right to receive one or more shares of common stock based on, and subject to, the achievement of certain clinical milestones determined by the Issuer's Compensation Committee in October 2019 as set forth in the Performance Share Award Agreement. The number of shares of common stock that the Reporting Person was entitled to receive ranged from 0% to 100% of the number of performance shares awarded, and the performance criteria was achieved at the 100% level. F2 · balance_after: This includes an aggregate of 63,951 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| October 29, 2019 Filed Oct 31, 2019 20:00 UTC |
Iyengar Vijay KEVP GPS, BD, & Licensing
|
SaleCommon Stock | 930 | $85.00 | $79,050.00 |
DisclosureSEC source: 0001209191-19-054616 · doc4.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP GPS, BD, & Licensing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,609 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F2 · balance_after: Includes an aggregate of 12,562 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.